Abrdn World Healthcare Fund (NYSE:THW – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 61,071 shares, a drop of 55.7% from the January 15th total of 137,777 shares. Based on an average daily volume of 233,897 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 233,897 shares, the short-interest ratio is presently 0.3 days.
Hedge Funds Weigh In On Abrdn World Healthcare Fund
Several institutional investors have recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. acquired a new position in Abrdn World Healthcare Fund in the second quarter valued at about $31,000. Advisory Services Network LLC bought a new position in shares of Abrdn World Healthcare Fund in the third quarter valued at approximately $43,000. Ameriflex Group Inc. acquired a new position in shares of Abrdn World Healthcare Fund in the 3rd quarter worth approximately $79,000. B. Riley Wealth Advisors Inc. bought a new stake in Abrdn World Healthcare Fund during the 2nd quarter worth approximately $113,000. Finally, HighTower Advisors LLC acquired a new stake in Abrdn World Healthcare Fund during the 4th quarter valued at $168,000.
Abrdn World Healthcare Fund Price Performance
THW stock traded down $0.04 during trading on Thursday, hitting $12.60. The company had a trading volume of 155,512 shares, compared to its average volume of 197,407. The company has a fifty day moving average price of $12.72 and a two-hundred day moving average price of $12.34. Abrdn World Healthcare Fund has a fifty-two week low of $9.80 and a fifty-two week high of $13.19.
Abrdn World Healthcare Fund Dividend Announcement
About Abrdn World Healthcare Fund
Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.
The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.
Featured Articles
- Five stocks we like better than Abrdn World Healthcare Fund
- Think You Missed Silver? You’re Wrong. Here’s Why.
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Trump’s AI Secret: 100X Faster Than Nvidia
- FREE BUY ALERT: 3 stocks to own in 2026
Receive News & Ratings for Abrdn World Healthcare Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn World Healthcare Fund and related companies with MarketBeat.com's FREE daily email newsletter.
